⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BNTX News
BioNTech SE American Depositary Share
Global Viral Vector and Plasmid DNA Manufacturing Market, 7th Edition: Forecast to 2035 | 9.73% CAGR Unlocks USD 2.16 Billion CMO and Gene Therapy Opportunity
globenewswire.com
CRL
CAT
TMO
NVS
BNTX
SNY
Electric Actuators Market Size, Share, Trends, and Global Forecast, 2026-2036 | Market to Reach USD 28.3 Billion as IIoT, Energy Efficiency, and Industrial Automation Accelerate Growth
globenewswire.com
EMR
HON
PAR
PCAR
ETN
AVGO
NVDA
MSFT
GOOG
AMZN
IBM
GE
NEE
XOM
CVX
LIN
AMAT
MU
ADI
TXN
QCOM
INTC
AMD
ACN
CDNS
SNPS
MRVL
ON
NXPI
STM
AEHR
TER
KLAC
LRCX
ASML
ENPH
SEDG
PLUG
FCEL
TSLA
RIVN
LCID
NIO
F
GM
STLD
NUE
CAT
DE
ROK
ILMN
REGN
GILD
BIIB
CRSP
BNTX
MRNA
COIN
PYPL
BITF
CLSK
MARA
RIOT
WEC
XEL
DUK
SO
AEP
PCG
SRE
HAL
SLB
APA
EOG
COP
DVN
VLO
MPC
PSX
ET
KMI
WMB
BKR
OXY
CW
TOL
OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors
prnewswire.com
BNTX
BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026
globenewswire.com
BNTX
BioNTech SE Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of BioNTech SE (BNTX)
accessnewswire.com
BNTX
Australia mRNA Therapeutics Market Size and Forecast to 2035 by Application and Disease Indication | 19% CAGR Drives USD 1.78 Billion Opportunity Across Influenza and RSV
globenewswire.com
PFE
ARCT
MRNA
BNTX
AZN
GSK
SNY
mRNA Drug Discovery and Manufacturing Platforms Market - Size, Share, Trends, and Forecast 2026-2031 | 11.5% CAGR to USD 0.81 Billion as Oncology and AI-Enabled R&D Scale
globenewswire.com
MRNA
BNTX
CVAC
PFE
GSK
BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)
prnewswire.com
BNTX
Engitix appoints Ryan Richardson to Board of Directors as company advances towards clinical development
globenewswire.com
BNTX
AUTL
BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer
globenewswire.com
BNTX